Provenge is first immunotherapy to gain approval
(AP) -
A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval today, offering an important alternative to more taxing treatments like chemotherapy. Dendreon Corp.'s Provenge vaccine trains the immune system to fight tumors. It's called a "vaccine" even though it treats...
More »
